Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PR Wording....

PR Wording....

posted on Mar 09, 2006 09:28AM
.`` The Company strongly believes that more licensing transactions and related revenues are likely, although none are assured. As in the instance of announcing this increased dividend, Patriot Scientific`s Board of Directors will continue to consider and decide whether to take such dividend payment actions in the future, based on future revenues and the financial condition of the Company, as well as market conditions and other factors.``

What does everyone make of this wording?

I take it as ``don`t expect more dividends any time soon``

Also I believe it is saying that the licensing agreements are not lined up ( NO Dozens waiting to sign on the dotted line), but for everyone to relax and just wait on the fundamentals of the cash flow as we get them in the future quarters to come.......Long up hill battle.

Share
New Message
Please login to post a reply